Aspira Women's Health Inc.
AWHL
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.98% | 4.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.98% | 4.08% | |||
| Cost of Revenue | -16.40% | -4.66% | |||
| Gross Profit | 4.77% | 9.89% | |||
| SG&A Expenses | -13.35% | 5.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -4.52% | -3.68% | |||
| Operating Income | 5.57% | 8.36% | |||
| Income Before Tax | -33.50% | 60.87% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -33.50% | 60.87% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -33.50% | 60.87% | |||
| EBIT | 5.57% | 8.36% | |||
| EBITDA | 5.56% | 8.17% | |||
| EPS Basic | -3.37% | 63.94% | |||
| Normalized Basic EPS | 57.70% | 11.95% | |||
| EPS Diluted | -3.37% | 63.94% | |||
| Normalized Diluted EPS | 57.70% | 11.95% | |||
| Average Basic Shares Outstanding | 29.17% | 8.50% | |||
| Average Diluted Shares Outstanding | 29.17% | 8.50% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||